权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Identification and characterization of cellular mechanisms which selectively cont

选择性控制细胞机制的鉴定和表征

基本信息

批准号：
8487345
负责人：
Brian Paul Dolan
金额：
$ 10.8万
依托单位：
OREGON STATE UNIVERSITY
依托单位国家：
美国
项目类别：
财政年份：
2012
资助国家：
美国
起止时间：
2012-06-15 至 2014-05-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/8487345
关键词：
Antigen Presentation Antigen Presentation Pathway Antigens Binding Biological Assay CD8B1 gene Cell physiology Cell surface Cells Chemicals Clinic Cytotoxic T-Lymphocytes Development Disease Disease model Elements Endoplasmic Reticulum Ensure Excision Generations Genes HLA A*0201 antigen Histocompatibility Antigens Class I Human Immune system Libraries MHC Class I Genes Measures Mediating Microbe Molecular Molecular Target Monitor Mus Nature Pathway interactions Peptide Fragments Peptide/MHC Complex Peptides Pharmaceutical Preparations Polyubiquitin Prostaglandins Protein Binding Protein Fragment Proteins Publishing Reagent Role Small Interfering RNA Source Specificity Surface System T cell response T-Lymphocyte Testing Tumor Cell Line Ubiquitin Ubiquitin-Conjugating Enzymes Ubiquitination Vaccine Therapy Viral Antigens Viral Proteins Virus Virus Diseases West Nile virus Work clinically relevant cytotoxic inhibitor/antagonist neuronal cell body prevent protein degradation response therapy design therapy development ubiquitin-protein ligase

项目摘要

DESCRIPTION (provided by applicant): Cytotoxic CD8+ T cells are defensive cells within the body that are responsible for eliminating self cells that have become infected with an intracellular microbe, such as a virus. To prevent elimination of otherwise healthy cells, cytotoxic T cells must first recognize a fragment of the disease-specific protein bound to an MHC class I molecule, which will be displayed on the surface of the diseased cell. While the peptide fragments may be derived due to the natural turnover of proteins within the cell, peptide-MHC complexes can be detected on the cell surface rapidly after the induction of protein antigen synthesis. This has led to the defective ribosomal product (or DRiP) hypothesis which states that a subset of newly synthesized protein will be defective and immediately degraded within the cell. This work will test the hypothesis that cells have a specific mechanism for generating protein antigens and will use a newly described assay that can segregate the sources of antigenic peptides into true DRiPs and peptides derived from the natural turnover of proteins. This assay has already indentified several chemicals and gene products which can selectively eliminate DRiP antigen presentation. These targets will be the starting point to identify the cellular mechanism(s) that govern how DRiPs are generated and targeted for antigen presentation. The ubiquitin conjugation and removal elements of the cell will be specifically monitored as they have been implicated in antigen presentation. The results of this work will have important implications for the development of vaccines and therapies that are designed to elicit cytotoxic T cell responses to a variety of diseases.

描述（由申请人提供）：细胞毒性CD 8 + T细胞是体内的防御性细胞，负责清除已被细胞内微生物（如病毒）感染的自身细胞。为了防止消除其他健康细胞，细胞毒性T细胞必须首先识别与MHC I类分子结合的疾病特异性蛋白的片段，该片段将展示在患病细胞的表面上。虽然肽片段可能是由于细胞内蛋白质的自然周转而衍生的，但在诱导蛋白质抗原合成后，可以在细胞表面上快速检测到肽-MHC复合物。这导致了有缺陷的核糖体产物（或DRiP）假说，该假说指出新合成的蛋白质的子集将是有缺陷的，并在细胞内立即降解。这项工作将测试细胞具有产生蛋白质抗原的特定机制的假设，并将使用一种新描述的测定法，该测定法可以将抗原肽的来源分离为真正的DRiP和源自蛋白质自然周转的肽。该试验已经鉴定了几种可以选择性消除DRiP抗原呈递的化学品和基因产物。这些靶标将是鉴定支配DRiP如何产生和靶向抗原呈递的细胞机制的起点。将特别监测细胞的泛素缀合和去除元件，因为它们涉及抗原呈递。这项工作的结果将对开发旨在引发对各种疾病的细胞毒性T细胞反应的疫苗和疗法产生重要影响。